ECR 2026: Bracco Showcases AI-Powered Brain MRI Solution AiMIFY

Bracco explores how AI can complement contrast media in next-generation imaging workflows

ECR 2026: DeepHealth and Gleamer Outline Vision for AI Scale and Consolidation in Radiology

Growing adoption of AI in radiology is driving demand for larger integrated platforms

Advancing Spectral CT: A First Clinical Experience with Philips Verida

Spectral imaging, faster workflows and lower radiation dose are shaping the next generation of CT diagnostics.

ECR 2026: Bayer Advances Precision Diagnostics with New Molecular Imaging Agents

New radiodiagnostic tracers aim to enable earlier and more precise detection of diseases such as cardiac amyloidosis

Japan Approves Low-Dose MRI Contrast Agent Ambelvist

Bayer has received the first global approval for its low-dose MRI contrast agent Ambelvist™ (gadoquatrane) in Japan.

Bayer Spotlights Next-Generation MRI and Low-Dose Contrast Agent Gadoquatrane at ECR 2026

At European Congress of Radiology (ECR) 2026, Bayer highlighted new developments in MRI technologies and contrast agents aimed at improving diagnostic efficiency and patient care.